Research & Development



  霍去病不喜歡這種狩獵式樣的作戰,他的軍事高貴病一旦發作就基本上沒有什麼可挽救的余地。   雲瑯點點頭道︰“硬橋不好修建,我們可以修建一座鐵索橋,反正瞎子河也不算寬,十二丈寬的河邊鐵索橋應該足夠過戰馬了。”av在线观看   “郎如意跟著去病一起去了,要打等他回來。”超碰在线视频人人av   可是,雲瑯沒有在鬼奴的身上看到這個特點。   眼看著大軍車隊出了白狼口,一群軍卒就歡呼一聲,圍在幕煙的身邊,仔細的打量雲瑯丟下的東西。人人日人人爱   說完話,這個剛剛剝奪了雲瑯指揮權的老賊就匆匆離開了山洞,畢竟,時不時地有黃土渣滓從頭頂掉下來,確實很不安全。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo